Ends on

20th World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease (WCIRDC)  Dates: December 1-3, 2022

Abstract Submission Deadline: Nov. 7, 2022

  • All Accepted Abstracts, submitted by registered participants, will be published in Metabolism, Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult
  • Accepted Abstracts will receive 40% off registration fees and will have the opportunity to present their poster(s) at the Abstract Hall.
  • Top Abstracts will be selected for oral presentation at the meeting. (In some cases, the committee may consider Late Breaking Abstracts for oral presentation.)
  • Top 4 Abstracts will receive awards and cash prizes.


Abstract Submission & Topics:
Clinical aspects of insulin resistance in childhood, adolescence and/or adulthood pertaining to: Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea

Basic science:
Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain

Abstract Guidelines:
Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease. Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.
The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level. To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.

Abstract Poster Presentations
Accepted abstracts may be submitted for a virtual poster presentation. If selected for virtual poster presentation, the author or presenter is required to register for the Congress.

Abstract Oral Presentations
4 of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session – for Time and Date please visit wcir.org/agenda. In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation.

Top Abstract Awards Awards will be given to the highest ranking abstracts. The award levels are: Gold, Silver, Bronze and honorable mentions and are chosen from the Abstract Oral Winners.

In addition:

  • Scientific materials presented at the 19th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2021) must not have been published or presented prior to December 2, 2021, other than in abstract form.
  • All abstracts must be submitted electronically and be no more than 250 words
  • Abstracts should NOT include any tables, graphs, figures or references
  • All materials must arrive on or before the abstract deadline noted.
  • Notification of acceptance will be e-mailed as soon as the committee accepts the abstract.
  • Authorship on multiple abstracts is permitted.
  • All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
  • Abstracts will be published in Metabolism, Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult

Poster Guidelines:
Generally, the poster print needs to be readable from three feet. The presentation areas accommodate posters that are sized 4 ft tall × 8 ft wide or less; you will be able to attach any sized poster that does not exceed these measurements. The most important data should be at eye level. View more on guidelines at wcir.org/poster-guidelines
1. The poster should flow horizontally ONLY.  2. The different sections should be physically distinct from each other, and labeled with headings. 3. Choose a font that is easy to read, e.g. Arial is more easily read than Times New Roman.  4. The print size should be 30 point or larger for the title. 5. The abstract print size should be no smaller than 22 point. 6. Different print sizes may be used in different sections of the poster text to emphasize certain points.  7. Color graphics should provide enough contrast to be well seen at three feet. A blue background with yellow text works well for both slides and prints.  8. Dark colors work well. Bright colors like red work well if the exposed margin is small. Pastels tend to appear washed out.

***ATTN: To be eligible for publishing, you must be a registered participant of the 20th WCIRDC.  If an author wishes to make changes or to withdraw their abstract, they must contact the WCIRDC team no later than November 12, 2022. WCIRDC cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via e-mail to info@tmioa.com 


We use Submittable to accept and review our submissions.